Two New Directors Added To Mindray Board In China
This article was originally published in PharmAsia News
China's Mindray Medical International has appointed two men knowledgeable in finances to its board of director. Peter Wan and Kern Lim will hold new seats on an expanded nine-member board and will serve on the Mindray board's committee overseeing corporate governance and compensation. Wan is a certified public accountant formerly with Pricewaterhouse Coopers and Lim, also a CPA, is a finance vice president at a Macao hotel. (Click here for more
You may also be interested in...
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.